0

non small cell lung cancer stage 3 prognosis

Báo cáo khoa học:

Báo cáo khoa học: " Absence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non-small cell lung cancer" pot

Báo cáo khoa học

... hypofractionated 3- dimensional radiation therapy for inoperable, early stage non- small cell lung cancer Sergio L Faria*1, Luis Souhami1, Lorraine Portelance1, Marie Duclos1, Te Vuong1, David Small 2 ... as lung cancer. It is more convenient for the patients and reduces health care costs.This study reports our results on patients with medically inoperable, early stage, non- small cell lung cancer ... hypofractionated radiation therapyis an attractive option for patients with early stage non- small cell lung cancer (NSCLC) who are not surgical can-didates. Although primarily appealing for...
  • 6
  • 391
  • 0
Báo cáo hóa học:

Báo cáo hóa học: " Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer" pdf

Hóa học - Dầu khí

... 70 34 3 194 34 0 60Age, yearsrange 36 -85 42- 83 27-88median 64 67 59.9Sexmale 28 31 36 female 50 30 34 EthnicityCaucasian 78 61 0 0 0Asian 0 0 70 34 3 60Smoking historysmokers 33 37 41 non- smokers ... ofEGFR mutations in non- small- cell lung cancer. Clin Cancer Res 2009,15 :30 23- 3028. 13. Motoi N, Szoke J, Riely GJ, Seshan VE, Kris MG, Rusch VW, Gerald WL,Travis WD: Lung adenocarcinoma: modification ... antibodies in lung cancer. Clin Cancer Res 2010, 16 :33 49 -33 55. 23. de Gunst MM, Gallegos-Ruiz MI, Giaccone G, Rodriguez JA: Functionalanalysis of cancer- associated EGFR mutants using a cellular assay...
  • 8
  • 798
  • 0
Báo cáo khoa học:

Báo cáo khoa học: "Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size" ppsx

Báo cáo khoa học

... of non- small- cell lung cancer. Int J Radiat Oncol Biol Phys 2002, 52 :38 2 -38 9.16. Qiao X, Tullgren O, Lax I, Sirzén F, Lewensohn R: The role of radiotherapyin treatment of stage I non- small cell ... 18Squamous cell carcinoma 35 0 19 16Unclassified NSCLC 13 0 10 3 Unproven 10 0 10 0Tumor locationCentral 29 0 18 11Peripheral 95 2 67 26Abbreviations: NSCLC = non- small cell lung cancer. Baba ... dose-volume histogram analysis for pneumonitis after 3Dtreatment for non- small cell lung cancer (NSCLC). Int J Radiat Oncol BiolPhys 1999, 45 :32 3 -32 9.25. Kwa SL, Lebesque JV, Theuws JC, Marks LB,...
  • 7
  • 297
  • 0
Báo cáo khoa học:

Báo cáo khoa học: " Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer" docx

Báo cáo khoa học

... iotherapy, Oligometastases, Non- Small Cell Lung Cancer Background Non- small cell lung cancer (NSCLC) is the leadingcause of cancer mortality in the United States [1].Patients with stage IV NSCLC typically ... of 7 RESEARC H Open AccessComparison of outcomes in patients with stage IIIversus limited stage IV non- small cell lung cancer Praveena Cheruvu1, Su K Metcalfe1, Justin Metcalfe1, Yuhchyau ... with NSCLC: stage III, stage IV, andrecurrent stage IV (initial stage I-II). All stage IV NSCLC patients treated with SBRT had ≤ 8 lesions.Results: Of 146 patients, 88% had KPS ≥ 80%, 30 % had >...
  • 7
  • 368
  • 0
Báo cáo khoa học:

Báo cáo khoa học: "Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study" pps

Báo cáo khoa học

... body radiotherapy for stage I non- small cell lung cancer. Radiother Oncol 2007, 85:429- 434 . 39 . Sinha B, McGarry RC: Stereotactic body radiotherapy for bilat-eral primary lung cancers: the Indiana ... MA, Slotman BJ, Lagerwaard FJ:Critical review of nonsurgical treatment options for stage I non- small cell lung cancer. Oncologist 2008, 13: 309 -31 9.41. Brock J, Ashley S, Bedford J, Nioutsikou ... surgery in patients withoperable lung cancer. A randomized phase III trial of Radiosurgery Or Surgeryfor operable Early stage (stage 1A) non- small cell Lung cancer (ROSEL, ClinicalTrials.gov...
  • 14
  • 308
  • 0
Báo cáo khoa học:

Báo cáo khoa học: " Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases" docx

Báo cáo khoa học

... peripheral stage I non- small cell lung cancer. Lung Cancer 1999, 26: 137 -142. 23. Slotman BJ, Antonisse IE, Njo KH: Limited field irradiation inearly stage (T1-2N0) non- small cell lung cancer. RadiotherOncol ... involving single-dose irradiation. With 25patients, 31 metastases in the lungs were irradiated; with each of 33 patients, stage I non- small cell lung cancer (NSCLC) was subject to irradiation. The ... WannenmacherM, Debus J: Stereotactic single-dose radiotherapy of stage I non- small- cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys20 03, 56 :33 5 -34 1.16. Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller...
  • 9
  • 329
  • 0
báo cáo hóa học:

báo cáo hóa học:" Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer" docx

Hóa học - Dầu khí

... Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001, 94:1 53- 156.2. Non- small Cell Lung Cancer Collaborative Group: Chemotherapyin non small cell lung cancer: a meta-analysis ... -Neutropenia 3 (8) 7 (18) 14* (36 ) 6 (16) 4 (11) 7†(8) Non hematologicalHepatotoxicity 4 (10) 3 (8) 0 - 5 ( 13) 3 (8) 1 (3) Mucositis 5 ( 13) 3 (8) 0 - 2 (5) 0 - 0 -Nausea 3 (8) 3 (8) 0 - 3 (8) 2 ... advanced non- small- cell lung cancer: a phase III trial of the European Organiza-tion for Research and Treatment of Cancer Lung Cancer Group – EORTC 08975. J Clin Oncol 20 03, 21 :39 09 -39 17.15....
  • 8
  • 538
  • 0
Báo cáo hóa học:

Báo cáo hóa học: "Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ Hybridization" pot

Hóa học - Dầu khí

... N+ 0. 034 Low 30 50 49 32 High 30 50 95 68 HR 0.45, CI 95% 0.21-0.96, P = 0. 039 AC (n = 95) 0.086Low 56 62 104 47High 38 37 71 33 HR 1.87, CI 95% 1.01 -3. 48, P = 0.047Missing 1 1AC, N0 0 .37 NSLow ... 14:2 53- 63. 23. Donnem T, Al-Saad S, Al-Shibli K, et al: Inverse prognostic impact ofangiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer. Clin Cancer ... MiR-155 in Non- Small Cell Lung Cancer Evaluated by in Situ HybridizationTom Donnem1,2*, Katrine Eklo 3, 4, Thomas Berg 3, 4, Sveinung W Sorbye 3, 4, Kenneth Lonvik 3, 4, Samer Al-Saad 3, 4,Khalid...
  • 9
  • 662
  • 0
báo cáo hóa học:

báo cáo hóa học: " Health state utilities for non small cell lung cancer" pot

Hóa học - Dầu khí

... Thun MJ: Cancer statistics, 20 03. CA Cancer J Clin 20 03, 53: 5-26.5. Busick NP, Fretz PC, Galvin JR, Peterson MW: Staging of small cell and non- small cell lung cancer. University of Iowa Virtual ... Treatment of Cancer Quality-of-Life Questionnaire -Lung Cancer- 17items; EQ-5D: EuroQoL-5 Dimensions; HRQL: Health-related Quality of Life; NSCLC: Non- Small Cell Lung Can-cer; SF -36 : Short-Form 36 items; ... with lung cancer: Implications for the eval-uation of palliative treatment. BR J Cancer 1995, 71: 633 - 636 .7. Krech RL, Davis J, Walsh D, Curtis EB: Symptoms of lung cancer. Palliat Med 1992, 6 :30 9 -31 5.8....
  • 15
  • 397
  • 0
Báo cáo toán học:

Báo cáo toán học: "Molecular Predictors of EGFR-TKI Sensitivity in Advanced Non–small Cell Lung Cancer" ppsx

Báo cáo khoa học

... Res. 19 93; 13( 4): 1 133 -7. 83. Ohsaki Y, Tanno S, Fujita Y, et al. Epidermal growth factor re-ceptor expression correlates with poor prognosis in non- small cell lung cancer patients with p 53 overexpression. ... ZD1 839 ) in non- small- cell lung can-cer. Br J Cancer. 2004; 91(2): 208-12. 89. Bailey R, Kris M, Wolf M. Gefitinib (Iressa, ZD 1 839 ) mono-therapy for pretreated advanced non- small cell lung cancer ... in non- small cell lung cancer Is correlated with survival. Clin Cancer Res. 2001; 7(7): 1850-5. 93. Cappuzzo F, Gregorc V, Rossi E, et al. Gefitinib in pretreated non- small- cell lung cancer...
  • 9
  • 203
  • 0
Báo cáo khoa học:

Báo cáo khoa học: "Pathological complete response induced by first-line chemotherapy with single agent docetaxel in a patient with advanced non small cell lung cancer" pptx

Báo cáo khoa học

... agentdocetaxel in a patient with advanced non small cell lung cancer Ferdinando Riccardi1*, Giuseppe Di Lorenzo1, Carlo Buonerba1, Guglielmo Monaco2, Roberto Monaco 3 ,Mimma Rizzo1, Sarah Scagliarini1, ... Carteni’1AbstractBackground: Defining the optimal treatment for patients with inoperable non small cell lung cancer (NSCLC),presenting with metastatic mediastinal lymph nodes, is challenging. Nevertheless, ... few cycles should notautomatically discourage to continue treatment.IntroductionIn non- small cell lung cancer (NSCLC), mediastinallymphnode involvement comprises a wide spectrum ofseverity....
  • 4
  • 303
  • 0
Báo cáo khoa học:

Báo cáo khoa học: "Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy" pot

Báo cáo khoa học

... 7.07%(1.94-8.82%) = 3. 15, SD = 1.94 = 4.89, SD = 2.150.007V55 6.75% (1 .33 -6 .32 %) = 2. 03, SD = 1.65 = 3. 19, SD = 1.750. 033 V60 5.76% (0.80-4.20%) = 1. 23, SD = 1.09 = 1.66, SD = 1.150. 039 Abbreviation: ... limited stage small cell lung cancer. Int J Radiat Oncol Biol Phys 1999, 43: 39-45. 31 . Rancati T, Ceresoli GL, Gagliardi G, Schipani S, Cattaneo GM: Factors predicting radiation pneumonitis in lung ... dose-volume histogram analysis for pneumonitis after 3D treatment for non- small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999, 45 :32 3 -32 9.15. Tsujino K, Hirota S, Endo M, Obayashi...
  • 8
  • 371
  • 0
Báo cáo khoa học:

Báo cáo khoa học: " Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer" potx

Báo cáo khoa học

... (%)COPD 30 (26)Cardiovascular disease 59 (52)Smoker 100 (87)Pathologic classification (%)Adenocarcinoma 43 (37 )Squamous cell carcinoma 39 (34 )Large cell carcinoma 3 (3) Mixed 2 (2) Non- small cell ... (IAEA)consultants' meeting on elective nodal irradiation in lung cancer: non- small cell lung cancer (NSCLC). Int J Radiat OncolBiol Phys 2008, 72(2) :33 5 -34 2.6. Therasse P, Arbuck SG, Eisenhauer EA, Wanders ... irradiation in combinationwith concurrent chemotherapy for inperable stage III nons-mall cell lung cancer. AM J Clin Oncol 2007, 30 : 239 -244.11. Bradley J, Graham MV, Winter K, Purdy JA, Komaki R,...
  • 7
  • 375
  • 0
Báo cáo khoa học:

Báo cáo khoa học: " Evalution of surface-based deformable image registration for adaptive radiotherapy of non-small cell lung cancer (NSCLC)" pptx

Báo cáo khoa học

... planning CT images was170 cm 3 (range 25 cm 3 - 35 3 cm 3 ); the GTV volumedecreased to median 124 cm 3 (19 cm 3 - 32 5 cm 3 ) and 100cm 3 (10 cm 3 - 270 cm 3 ) mid-way and at the end of ... was observed with median GTV volumes of 170 cm 3 (range 42 cm 3 - 35 3 cm 3 ), 124 cm 3 (19 cm 3 - 32 5 cm 3 ) and 100 cm 3 (10 cm 3 - 270 cm 3 ) at treatmentplanning, mid-way and at the end ... 5.7Carina 6.0 ± 3. 2 10 4.5 ± 2.5 6.5Pulmonary landmarks - same lobe as GTV8 .3 ± 3. 8 15 5.5 ± 2 .3 11Pulmonary landmarks - different lobes as GTV8.0 ± 3. 8 13 6 .3 ± 2.8 13 Radiation Oncology...
  • 13
  • 255
  • 0
Báo cáo khoa học:

Báo cáo khoa học: " Accelerated high-dose radiotherapy alone or combined with either concomitant or sequential chemotherapy; treatments of choice in patients with Non-Small Cell Lung Cancer" pps

Báo cáo khoa học

... unresecta-ble stage IIIA and B non- small- cell lung cancer. J Clin Oncol2005, 23: 3760 -37 67.46. El Sharouni SY, Kal HB, Battermann JJ: Accelerated regrowth of non- small- cell lung tumours after ... for stage I Nonsmall cell lung carcinoma. Cancer 2004,101:16 23- 1 631 .54. Belderbos J, Heemsbergen W, Hoogeman M, Pengel K, Rossi M, Leb-esque J: Acute esophageal toxicity in non- small cell lung ... chemoradiotherapy in non- small cell lung cancer (Review). In The Cochrane Library Vol-ume 1. Wiley; 2005:1 -37 . 25. Vokes EE: Optimal therapy for unresectable stage III non- small- cell lung cancer. J Clin...
  • 10
  • 336
  • 0

Xem thêm